Americans who live in poorer, urban areas and those who have less income are least likely to consume healthy food, regardless of their access to it, according to a study published in the American Heart Association’s journal Circulation.

Most of us might equate type 2 diabetes with too much sugar, but a recent Swedish study found that risk of developing diabetes correlated to salt intake in the country’s population.

Overtreatment of diabetes in elderly patients could be contributing to an increase in the number of falls, dizzy spells and confusion those individuals experience, according to research published in the Journal of General Internal Medicine.

Veterinarians at Cornell University are reviving a procedure to treat horses with atrial fibrillation (AFib).

A 25-year study of young adults transitioning to middle age revealed maintaining a healthy weight was more important in blood pressure control than four other health behaviors.

Overweight and obese individuals with suspected coronary artery disease could be at increased risk for endothelial dysfunction, according to a study published in the Journal of the American Heart Association.

LEXINGTON, Mass., Sept. 14, 2017 — G3 Pharmaceuticals, a newly formed biopharmaceutical company located in Lexington, MA, today announced the start of its research and development program to pursue novel galectin-3 inhibitors.   Galectin-3 is a protein that is responsible for fibrosis forming in the heart and kidney, which impairs organ function, leading to heart failure, atrial fibrillation, and impaired kidney function.

Amgen (NASDAQ:AMGN) today announced that a new analysis of the cardiovascular outcomes study (FOURIER) demonstrated that lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) significantly and consistently reduced cardiovascular events in patients with and without diabetes at baseline.